This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
BB Aggarwal (2003). Signalling pathways of the TNF superfamily: a double-edged sword. Nature Reviews. Immunology 3, 745–756.
BC Albensi , MP Mattson (2000). Evidence for the involvement of TNF and NF-kappaB in hippocampal synaptic plasticity. Synapse 35, 151–159.
L Aloe , F Properzi , L Probert , K Akassoglou , G Kassiotis , A Micera , M Fiore (1999). Learning abilities, NGF and BDNF brain levels in two lines of TNF-alpha transgenic mice, one characterized by neurological disorders, the other phenotypically normal. Brain Research 840, 125–137.
H Anisman , AV Ravindran , J Griffiths , Z Merali (1999). Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biological Psychiatry 46, 1649–1655.
B Asefa , KD Klarmann , NG Copeland , DJ Gilbert , NA Jenkins , JR Keller (2004). The interferon-inducible p200 family of proteins: a perspective on their roles in cell cycle regulation and differentiation. Blood Cells, Molecules and Diseases 32, 155–167.
A Avital , I Goshen , A Kamsler , M Segal , K Iverfeldt , G Richter-Levin , R Yirmiya (2003). Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13, 826–834.
M Banasr , RS Duman (2007). Regulation of neurogenesis and gliogenesis by stress and antidepressant treatment. CNS and Neurological Disorders Drug Targets 6, 311–320.
M Banasr , RS Duman (2008). Glial loss in the prefrontal cortex is sufficient to induce depressive-like behaviors. Biological Psychiatry 64, 863–870.
RM Barrientos , EA Higgins , DB Sprunger , LR Watkins , JW Rudy , SF Maier (2002). Memory for context is impaired by a post context exposure injection of interleukin-1 beta into dorsal hippocampus. Behavioural Brain Research 134, 291–298.
E Bartee , MR Mohamed , G McFadden (2008). Tumor necrosis factor and interferon: cytokines in harmony. Current Opinion in Microbiology 11, 378–383.
EC Beattie , D Stellwagen , W Morishita , JC Bresnahan , BK Ha , M Von Zastrow , MS Beattie , RC Malenka (2002). Control of synaptic strength by glial TNFalpha. Science 295, 2282–2285.
FP Bellinger , S Madamba , GR Siggins (1993). Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Research 628, 227–234.
LI Benowitz , NI Perrone-Bizzozero (1991). The relationship of GAP-43 to the development and plasticity of synaptic connections. Annals of the New York Academy of Sciences 627, 58–74.
EN Benveniste (1998). Cytokine actions in the central nervous system. Cytokine & Growth Factor Reviews 9, 259–275.
YB Bezchlibnyk , JF Wang , GM McQueen , LT Young (2001). Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. Journal of Neurochemistry 79, 826–834.
TV Bliss , GL Collingridge (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31–39.
RM Bluthe , N Castanon , F Pousset , A Bristow , C Ball , J Lestage , B Michaud , KW Kelley , R Dantzer (1999). Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats. Psychoneuroendocrinology 24, 301–311.
G Boka , P Anglade , D Wallach , F Javoy-Agid , Y Agid , EC Hirsch (1994). Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease. Neuroscience Letters 172, 151–154.
S Bonaccorso , V Marino , M Biondi , F Grimaldi , F Ippoliti , M Maes (2002). Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus. Journal of Affective Disorders 72, 237–241.
S Bonaccorso , A Puzella , V Marino , M Pasquini , M Biondi , M Artini , C Almerighi , M Levrero , B Egyed , E Bosmans , HY Meltzer , M Maes (2001). Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Research 105, 45–55.
F Brambilla , M Maggioni (1998). Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatrica Scandinavica 97, 309–313.
CD Breder , M Tsujimoto , Y Terano , DW Scott , CB Saper (1993). Distribution and characterization of tumor necrosis factor-alpha-like immunoreactivity in the murine central nervous system. Journal of Comparative Neurology 337, 543–567.
FX Brennan , KD Beck , RJ Servatius (2003). Low doses of interleukin-1beta improve the leverpress avoidance performance of Sprague-Dawley rats. Neurobiology of Learning and Memory 80, 168–171.
MP Butler , JJ O'Connor , PN Moynagh (2004). Dissection of tumor-necrosis factor-alpha inhibition of long-term potentiation (LTP) reveals a p38 mitogen-activated protein kinase-dependent mechanism which maps to early-but not late-phase LTP. Neuroscience 124, 319–326.
L Capuron , A Ravaud , R Dantzer (2001 a). Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients. Psychosomatic Medicine 63, 376–386.
L Capuron , A Ravaud , N Gualde , E Bosmans , R Dantzer , M Maes , PJ Neveu (2001 b). Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26, 797–808.
WA Carlezon Jr., EJ Nestler (2002). Elevated levels of GluR1 in the midbrain: a trigger for sensitization to drugs of abuse? Trends in Neurosciences 25, 610–615.
LL Carpenter , GR Heninger , RT Malison , AR Tyrka , LH Price (2004). Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression. Journal of Affective Disorders 79, 285–289.
JT Cavanagh , M Van Beck , W Muir , DH Blackwood (2002). Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. British Journal of Psychiatry 180, 320–326.
PV Choudary , M Molnar , SJ Evans , H Tomita , JZ Li , MP Vawter , RM Myers , WE Bunney Jr., H Akil , SJ Watson , EG Jones (2005). Altered cortical glutamatergic and GABAergic signal transmission with glial involvement in depression. Proceedings of the National Academy of Sciences USA 102, 15653–15658.
L Churchill , DM Rector , K Yasuda , C Fix , MJ Rojas , T Yasuda , JM Krueger (2008). Tumor necrosis factor alpha: activity dependent expression and promotion of cortical column sleep in rats. Neuroscience 156, 71–80.
TJ Connor , BE Leonard (1998). Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sciences 62, 583–606.
AN Coogan , LA O'Neill , JJ O'Connor (1999). The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93, 57–69.
SC Cook CL Wellman (2004). Chronic stress alters dendritic morphology in rat medial prefrontal cortex. Journal of Neurobiology 60, 236–248.
AJ Cunningham , CA Murray , LA O'Neill , MA Lynch , JJ O'Connor (1996). Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neuroscience Letters 203, 17–20.
B Curran , JJ O'Connor (2001). The pro-inflammatory cytokine interleukin-18 impairs long-term potentiation and NMDA receptor-mediated transmission in the rat hippocampus in vitro. Neuroscience 108, 83–90.
B Czeh , M Simon , B Schmelting , C Hiemke , E Fuchs (2006). Astroglial plasticity in the hippocampus is affected by chronic psychosocial stress and concomitant fluoxetine treatment. Neuropsychopharmacology 31, 1616–1626.
G D'Arcangelo , V Tancredi , F Onofri , M D'Antuono , S Giovedi , F Benfenati (2000). Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. European Journal of Neuroscience 12, 1241–1252.
R Dantzer (1999). Mechanisms of the behavioral effects of cytokines. In: Cytokines, Stress and Depression. New York: Kluwer Academic/Plenum Publishers.
R Dantzer (2001). Cytokine-induced sickness behavior: mechanisms and implications. Annals of the New York Academy of Sciences 933, 222–234.
R Dantzer , JC O'Connor , GG Freund , RW Johnson , KW Kelley (2008). From inflammation to sickness and depression: when the immune system subjugates the brain. Nature Reviews Neuroscience 9, 46–56.
R de Beaurepaire (2002). Questions raised by the cytokine hypothesis of depression. Brain, Behavior, and Immunity 16, 610–617.
DJ de Quervain , B Roozendaal , RM Nitsch , JL McGaugh , C Hock (2000). Acute cortisone administration impairs retrieval of long-term declarative memory in humans. Nature Neuroscience 3, 313–314.
R Deinzer , N Granrath , H Stuhl , L Twork , H Idel , B Waschul , A Herforth (2004). Acute stress effects on local Il-1beta responses to pathogens in a human in vivo model. Brain, Behavior, and Immunity 18, 458–467.
E Dieperink , SB Ho , P Thuras , ML Willenbring (2003). A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 44, 104–112.
E Dieperink , M Willenbring , SB Ho (2000). Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: A review. American Journal of Psychiatry 157, 867–876.
J Du , TK Creson , LJ Wu , M Ren , NA Gray , C Falke , Y Wei , Y Wang , R Blumenthal , R Machado-Vieira , (2008). The role of hippocampal GluR1 and GluR2 receptors in manic-like behavior. Journal of Neuroscience 28, 68–79.
J Du , NA Gray , CA Falke , W Chen , P Yuan , ST Szabo , H Einat , HK Manji (2004). Modulation of synaptic plasticity by antimanic agents: the role of AMPA glutamate receptor subunit 1 synaptic expression. Journal of Neuroscience 24, 6578–6589.
J Du , K Suzuki , Y Wei , Y Wang , R Blumenthal , Z Chen , C Falke , CA Zarate Jr., HK Manji (2007). The anticonvulsants lamotrigine, riluzole, and valproate differentially regulate AMPA receptor membrane localization: relationship to clinical effects in mood disorders. Neuropsychopharmacology 32, 793–802.
RS Duman (2004). Depression: a case of neuronal life and death? Biological Psychiatry 56, 140–145.
SL Eastwood , PJ Harrison (2001). Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Research Bulletin 55, 569–578.
T Eller , V Vasar , J Shlik , E Maron (2008). Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry 32, 445–450.
B Fahey , S Barlow , JS Day , SM O'Mara (2008). Interferon-alpha-induced deficits in novel object recognition are rescued by chronic exercise. Physiology & Behavior 95, 125–129.
SM Fertuzinhos , JR Oliveira , AL Nishimura , D Pontual , DR Carvalho , EB Sougey , PA Otto , M Zatz (2004). Analysis of IL-1alpha, IL-1beta, and IL-1RA [correction of IL-RA] polymorphisms in dysthymia. Journal of Molecular Neuroscience 22, 251–256.
WJ Friedman (2001). Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Experimental Neurology 168, 23–31.
MM Gabellec , R Griffais , G Fillion , F Haour (1996). Interleukin-1 receptors type I and type II in the mouse brain: kinetics of mRNA expressions after peripheral administration of bacterial lipopolysaccharide. Journal of Neuroimmunology 66, 65–70.
RA Gadient , U Otten (1994). Expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat brain during postnatal development. Brain Research 637, 10–14.
D Gayle , SE Ilyin , MC Flynn , CR Plata-Salaman (1998). Lipopolysaccharide (LPS)- and muramyl dipeptide (MDP)-induced anorexia during refeeding following acute fasting: characterization of brain cytokine and neuropeptide systems mRNAs. Brain Research 795, 77–86.
M Gibertini , C Newton , H Friedman TW Klein (1995). Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta. Brain, Behavior, and Immunity 9, 113–128.
MU Goebel , PJ Mills , MR Irwin , MG Ziegler (2000). Interleukin-6 and tumor necrosis factor-alpha production after acute psychological stress, exercise, and infused isoproterenol: differential effects and pathways. Psychosomatic Medicine 62, 591–598.
DC Goff , L Leahy , I Berman , T Posever , L Herz , AC Leon , SA Johnson , G Lynch (2001). A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia. Journal of Clinical Psychopharmacology 21, 484–487.
H Golan , T Levav , A Mendelsohn , M Huleihel (2004). Involvement of tumor necrosis factor alpha in hippocampal development and function. Cerebral Cortex 14, 97–105.
I Goshen , T Kreisel , O Ben-Menachem-Zidon , T Licht , J Weidenfeld , T Ben-Hur , R Yirmiya (2008). Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Molecular Psychiatry 13, 717–728.
I Goshen , T Kreisel , H Ounallah-Saad , P Renbaum , Y Zalzstein , T Ben-Hur , E Levy-Lahad , R Yirmiya (2007). A dual role for interleukin-1 in hippocampal-dependent memory processes. Psychoneuroendocrinology 32, 1106–1115.
M Grilli , M Memo (1999). Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction. Biochemical Pharmacology 57, 1–7.
S Hashioka , A Klegeris , A Monji , T Kato , M Sawada , PL McGeer , S Kanba (2007). Antidepressants inhibit interferon-gamma-induced microglial production of IL-6 and nitric oxide. Experimental Neurology 206, 33–42.
PC Heinrich , I Behrmann , G Muller-Newen , F Schaper , L Graeve (1998). Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical Journal 334, 297–314.
KA Hestad , S Tonseth , CD Stoen , T Ueland , P Aukrust (2003). Raised plasma levels of tumor necrosis factor alpha in patients with depression: normalization during electroconvulsive therapy. Journal of ECT 19, 183–188.
CJ Heyser , E Masliah , A Samimi , IL Campbell , LH Gold (1997). Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proceedings of the National Academy of Sciences USA 94, 1500–1505.
LJ Hofseth , SP Hussain , CC Harris (2004). p53: 25 years after its discovery. Trends in Pharmacological Sciences 25, 177–181.
R Holderbach , K Clark , JL Moreau , J Bischofberger , C Normann (2007). Enhanced long-term synaptic depression in an animal model of depression. Biological Psychiatry 62, 92–100.
S Holmin , M Schalling , B Hojeberg , AC Nordqvist , AK Skeftruna , T Mathiesen (1997). Delayed cytokine expression in rat brain following experimental contusion. Journal of Neurosurgery 86, 493–504.
JS Hunt , HL Chen , XL Hu , TY Chen , DC Morrison (1992). Tumor necrosis factor-alpha gene expression in the tissues of normal mice. Cytokine 4, 340–346.
TA Ignatowski , BK Noble , JR Wright , JL Gorfien , RR Heffner , RN Spengler (1997). Neuronal-associated tumor necrosis factor (TNF alpha): its role in noradrenergic functioning and modification of its expression following antidepressant drug administration. Journal of Neuroimmunology 79, 84–90.
K Iwamoto , C Kakiuchi , M Bundo , K Ikeda , T Kato (2004). Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Molecular Psychiatry 9, 406–416.
TY Jun , CU Pae , H Hoon , JH Chae , WM Bahk , KS Kim , A Serretti (2003). Possible association between-G308A tumour necrosis factor-alpha gene polymorphism and major depressive disorder in the Korean population. Psychiatric Genetics 13, 179–181.
SF Kendell , JH Krystal , G Sanacora (2005). GABA and glutamate systems as therapeutic targets in depression and mood disorders. Expert Opinion on Therapeutic Targets 9, 153–168.
KS Kendler , LM Thornton , CO Gardner (2000). Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the ‘kindling’ hypothesis. American Journal of Psychiatry 157, 1243–1251.
G Kenis , M Maes (2002). Effects of antidepressants on the production of cytokines. International Journal of Neuropsychopharmacology 5, 401–412.
S Kent , RM Bluthe , KW Kelley , R Dantzer (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Sciences 13, 24–28.
YK Kim , KS Na , KH Shin , HY Jung , SH Choi , JB Kim (2007). Cytokine imbalance in the pathophysiology of major depressive disorder. Progress in Neuro-psychopharmacology and Biological Psychiatry 31, 1044–1053.
R Krishnan , D Cella , C Leonardi , K Papp , AB Gottlieb , M Dunn , CF Chiou , V Patel , A Jahreis (2007). Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks. British Journal of Dermatology 157, 1275–1277.
S Lacroix , S Rivest (1998). Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. Journal of Neurochemistry 70, 452–466.
S Lanquillon , JC Krieg , U Bening-Abu-Shach , H Vedder (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 22, 370–379.
SJ Larson , AJ Dunn (2001). Behavioral effects of cytokines. Brain, Behavior, and Immunity 15, 371–387.
Y Levkovitz , N Grisaru , M Segal (2001). Transcranial magnetic stimulation and antidepressive drugs share similar cellular effects in rat hippocampus. Neuropsychopharmacology 24, 608–616.
AP Lieberman , PM Pitha , HS Shin , ML Shin (1989). Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proceedings of the National Academy of Sciences USA 86, 6348–6352.
GM MacQueen , S Campbell , BS McEwen , K Macdonald , S Amano , RT Joffe , C Nahmias , LT Young (2003). Course of illness, hippocampal function, and hippocampal volume in major depression. Proceedings of the National Academy of Sciences USA 100, 1387–1392.
JL Madrigal , O Hurtado , MA Moro , I Lizasoain , P Lorenzo , A Castrillo , L Bosca , JC Leza (2002). The increase in TNF-alpha levels is implicated in NF-kappaB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology 26, 155–163.
M Maes (1994). Cytokines in major depression. Biological Psychiatry 36, 498–499.
M Maes , HY Meltzer , E Bosmans , R Bergmans , E Vandoolaeghe , R Ranjan , R Desnyder (1995 a). Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. Journal of Affective Disorders 34, 301–309.
M Maes , R Smith , S Scharpe (1995 b). The monocyte-T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology 20, 111–116.
M Maes , DR Van Bockstaele , A Gastel , C Song , C Schotte , H Neels , I DeMeester , S Scharpe , A Janca (1999). The effects of psychological stress on leukocyte subset distribution in humans: evidence of immune activation. Neuropsychobiology 39, 1–9.
SF Maier , LR Watkins (1995). Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock. Brain Research 695, 279–282.
SF Maier , LR Watkins (1998). Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Review 105, 83–107.
RC Malenka (2003). The long-term potential of LTP. Nature Reviews. Neuroscience 4, 923–926.
HK Manji , JA Quiroz , J Sporn , JL Payne , KD Denicoff , CA Zarate Jr., DS Charney (2003). Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry 53, 707–742.
C Mastronardi , F Whelan , OA Yildiz , J Hannestad , D Elashoff , SM McCann , J Licinio , ML Wong (2007). Caspase 1 deficiency reduces inflammation-induced brain transcription. Proceedings of the National Academy of Sciences USA 104, 7205–7210.
V Mendoza-Fernandez , RD Andrew , C Barajas-Lopez (2000). Interferon-alpha inhibits long-term potentiation and unmasks a long-term depression in the rat hippocampus. Brain Research 885, 14–24.
AH Miller , CL Raison (2006). Cytokines, p38 MAP kinase and the pathophysiology of depression. Neuropsychopharmacology 31, 2089–2090.
GE Miller , KE Freedland , RM Carney , CA Stetler , WA Banks (2003). Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain, Behavior, and Immunity 17, 276–285.
GE Miller , N Rohleder , C Stetler , C Kirschbaum (2005). Clinical depression and regulation of the inflammatory response during acute stress. Psychosomatic Medicine 67, 679–687.
GE Miller , CA Stetler , RM Carney , KE Freedland , WA Banks (2002). Clinical depression and inflammatory risk markers for coronary heart disease. American Journal of Cardiology 90, 1279–1283.
I Mizuta , M Ohta , K Ohta , M Nishimura , E Mizuta , S Kuno (2001). Riluzole stimulates nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor synthesis in cultured mouse astrocytes. Neuroscience Letters 310, 117–120.
N Muller , M Ackenheil (1998). Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Progress in Neuropsychopharmacology and Biological Psychiatry 22, 1–33.
N Muller , M Schwarz (2006). Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission. Neurotoxicity Research 10, 131–148.
N Muller , MJ Schwarz , S Dehning , A Douhe , A Cerovecki , B Goldstein-Muller , I Spellmann , G Hetzel , K Maino , N Kleindienst , (2006). The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Molecular Psychiatry 11, 680–684.
AM Myint , S O'Mahony , M Kubera , YK Kim , C Kenny , A Kaim-Basta , HW Steinbusch , BE Leonard (2007). Role of paroxetine in interferon-alpha-induced immune and behavioural changes in male Wistar rats. Journal of Psychopharmacology 21, 843–850.
L Nassberger , L Traskman-Bendz (1993). Increased soluble interleukin-2 receptor concentrations in suicide attempters. Acta Psychiatrica Scandinavica 88, 48–52.
FG Nery , ES Monkul , JP Hatch , M Fonseca , GB Zunta-Soares , BN Frey , CL Bowden , JC Soares (2008). Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study. Human Psychopharmacology 23, 87–94.
JW Newcomer , G Selke , AK Melson , T Hershey , S Craft , K Richards , AL Alderson (1999). Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Archives of General Psychiatry 56, 527–533.
SM O'Brien , P Scully , LV Scott , TG Dinan (2006). Cytokine profiles in bipolar affective disorder: focus on acutely ill patients. Journal of Affective Disorders 90, 263–267.
KA O'Connor , JD Johnson , MK Hansen , JL Wieseler Frank , E Maksimova , LR Watkins , SF Maier (2003). Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Research 991, 123–132.
MS Oitzl , H van Oers , B Schobitz , ER de Kloet (1993). Interleukin-1 beta, but not interleukin-6, impairs spatial navigation learning. Brain Research 613, 160–163.
D Ongur , WC Drevets , JL Price (1998). Glial reduction in the subgenual prefrontal cortex in mood disorders. Proceedings of the National Academy of Sciences USA 95, 13290–13295.
RC Padmos , MH Hillegers , EM Knijff , R Vonk , A Bouvy , FJ Staal , D de Ridder , RW Kupka , WA Nolen , HA Drexhage (2008). A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. Archives of General Psychiatry 65, 395–407.
P Parnet , S Amindari , C Wu , D Brunke-Reese , E Goujon , JA Weyhenmeyer , R Dantzer , KW Kelley (1994). Expression of type I and type II interleukin-1 receptors in mouse brain. Brain research. Molecular Brain Research 27, 63–70.
M Pickering , D Cumiskey , JJ O'Connor (2005). Actions of TNF-alpha on glutamatergic synaptic transmission in the central nervous system. Experimental Physiology 90, 663–670.
F Pitossi , A del Rey , A Kabiersch , H Besedovsky (1997). Induction of cytokine transcripts in the central nervous system and pituitary following peripheral administration of endotoxin to mice. Journal of Neuroscience Research 48, 287–298.
M Pizzi , I Sarnico , F Boroni , M Benarese , M Dreano , G Garotta , A Valerio , P Spano (2004). Prevention of neuron and oligodendrocyte degeneration by interleukin-6 (IL-6) and IL-6 receptor/IL-6 fusion protein in organotypic hippocampal slices. Molecular and Cellular Neurosciences 25, 301–311.
T Pollmacher , M Haack , A Schuld , A Reichenberg , R Yirmiya (2002). Low levels of circulating inflammatory cytokines – do they affect human brain functions? Brain, Behavior, and Immunity 16, 525–532.
CR Pugh , JD Johnson , D Martin , JW Rudy , SF Maier , LR Watkins (2000). Human immunodeficiency virus-1 coat protein gp120 impairs contextual fear conditioning: a potential role in AIDS related learning and memory impairments. Brain Research 861, 8–15.
CR Pugh , KT Nguyen , JL Gonyea , M Fleshner , LR Wakins , SF Maier , JW Rudy (1999). Role of interleukin-1 beta in impairment of contextual fear conditioning caused by social isolation. Behavioural Brain Research 106, 109–118.
CL Raison , L Capuron , AH Miller (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24–31.
G Rajkowska (2000). Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biological Psychiatry 48, 766–777.
G Rajkowska (2002). Cell pathology in mood disorders. Seminars in Clinical Neuropsychiatry 7, 281–292.
G Rajkowska , A Halaris , LD Selemon (2001). Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biological Psychiatry 49, 741–752.
G Rajkowska , JJ Miguel-Hidalgo (2007). Gliogenesis and glial pathology in depression. CNS & Neurological Disorders Drug Targets 6, 219–233.
V Rettori , N Belova , A Kamat , K Lyson , M Gimeno , SM McCann (1994). Blockade by interleukin-1-alpha of nitricoxidergic control of luteinizing hormone-releasing hormone release in vivo and in vitro. Neuroimmunomodulation 1, 86–91.
JL Reynolds TA Ignatowski R Sud RN Spengler (2004). Brain-derived tumor necrosis factor-alpha and its involvement in noradrenergic neuron functioning involved in the mechanism of action of an antidepressant. Journal of Pharmacology and Experimental Therapeutics 310, 1216–1225.
JL Reynolds , TA Ignatowski , R Sud , RN Spengler (2005). An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience 133, 519–531.
S Rivest , S Lacroix , L Vallieres , S Nadeau , J Zhang , N Laflamme (2000). How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proceedings of the Society for Experimental Biology and Medicine 223, 22–38.
C Rocher , M Spedding , C Munoz , TM Jay (2004). Acute stress-induced changes in hippocampal/prefrontal circuits in rats: effects of antidepressants. Cerebral Cortex 14, 224–229.
A Rosa , V Peralta , S Papiol , MJ Cuesta , F Serrano , A Martinez-Larrea , L Fananas (2004). Interleukin-1beta (IL-1beta) gene and increased risk for the depressive symptom-dimension in schizophrenia spectrum disorders. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics 124B, 10–14.
M Rothermundt , V Arolt , J Fenker , H Gutbrodt , M Peters , H Kirchner (2001). Different immune patterns in melancholic and non-melancholic major depression. European Archives of Psychiatry and Clinical Neuroscience 251, 90–97.
C Roumestan , A Michel , F Bichon , K Portet , M Detoc , C Henriquet , D Jaffuel , M Mathieu (2007). Anti-inflammatory properties of desipramine and fluoxetine. Respiratory Research 8, 35.
RM Sapolsky (2003). Stress and plasticity in the limbic system. Neurochemical Research 28, 1735–1742.
OJ Schiepers , MC Wichers , M Maes (2005). Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 29, 201–217.
RJ Schloesser , J Huang , PS Klein , HK Manji (2008). Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33, 110–133.
H Schneider , F Pitossi , D Balschun , A Wagner , A del Rey , HO Besedovsky (1998). A neuromodulatory role of interleukin-1beta in the hippocampus. Proceedings of the National Academy of Sciences USA 95, 7778–7783.
B Schobitz , M Van Den Dobbelsteen , F Holsboer , W Sutanto , ER De Kloet (1993). Regulation of interleukin 6 gene expression in rat. Endocrinology 132, 1569–1576.
JD Sedgwick , C Czerkinsky (1992). Detection of cell-surface molecules, secreted products of single cells and cellular proliferation by enzyme immunoassay. Journal of Immunological Methods 150, 159–175.
YI Sheline (2000). 3D MRI studies of neuroanatomic changes in unipolar major depression: the role of stress and medical comorbidity. Biological Psychiatry 48, 791–800.
TJ Shors (2006). Significant life events and the shape of memories to come: a hypothesis. Neurobiology of Learning and Memory 85, 103–115.
BB Simen , CH Duman , AA Simen , RS Duman (2006). TNFalpha signaling in depression and anxiety: behavioral consequences of individual receptor targeting. Biological Psychiatry 59, 775–785.
A Sluzewska (1999). Indicators of immune activation in depressed patients. Advances in Experimental Medicine and Biology 461, 59–73.
C Song , AG Phillips , B Leonard (2003). Interleukin 1 beta enhances conditioned fear memory in rats: possible involvement of glucocorticoids. European Journal of Neuroscience 18, 1739–1743.
LR Squire , CE Stark , RE Clark (2004). The medial temporal lobe. Annual Review of Neuroscience 27, 279–306.
D Stellwagen , EC Beattie , JY Seo , RC Malenka (2005). Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. Journal of Neuroscience 25, 3219–3228.
D Stellwagen , RC Malenka (2006). Synaptic scaling mediated by glial TNF-alpha. Nature 440, 1054–1059.
CA Stewart , IC Reid (2000). Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity. Psychopharmacology 148, 217–223.
X Sun , Y Zhao , ME Wolf (2005). Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons. Journal of Neuroscience 25, 7342–7351.
L Sutcigil , C Oktenli , U Musabak , A Bozkurt , A Cansever , O Uzun , SY Sanisoglu , Z Yesilova , N Ozmenler , A Ozsahin , A Sengul (2007). Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clinical and Developmental Immunology 2007, 26438.
M Taler , M Bar , I Korob , L Lomnitski , E Baharav , N Grunbaum-Novak , A Weizman , I Gil-Ad (2008). Evidence for an inhibitory immunomodulatory effect of selected antidepressants on rat splenocytes: possible relevance to depression and hyperactive-immune disorders. International Immunopharmacology 8, 526–533.
M Taler , I Gil-Ad , L Lomnitski , I Korov , E Baharav , M Bar , A Zolokov , A Weizman (2007). Immunomodulatory effect of selective serotonin reuptake inhibitors (SSRIs) on human T lymphocyte function and gene expression. European Neuropsychopharmacology 17, 774–780.
V Tancredi , M D'Antuono , C Cafe , S Giovedi , MC Bue , G D'Arcangelo , F Onofri , F Benfenati (2000). The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. Journal of Neurochemistry 75, 634–643.
V Tancredi , G D'Arcangelo , F Grassi , P Tarroni , G Palmieri , A Santoni , F Eusebi (1992). Tumor necrosis factor alters synaptic transmission in rat hippocampal slices. Neuroscience Letters 146, 176–178.
KQ Tanis , SS Newton , RS Duman (2007). Targeting neurotrophic/growth factor expression and signaling for antidepressant drug development. CNS & Neurological Disorders Drug Targets 6, 151–160.
JL Tchelingerian , J Quinonero , J Booss , C Jacque (1993). Localization of TNF alpha and IL-1 alpha immunoreactivities in striatal neurons after surgical injury to the hippocampus. Neuron 10, 213–224.
D Tkachev , ML Mimmack , MM Ryan , M Wayland , T Freeman , PB Jones , M Starkey , MJ Webster , RH Yolken , S Bahn (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798–805.
LH Tonelli , TT Postolache (2005). Tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and major histocompatibility complex molecules in the normal brain and after peripheral immune challenge. Neurological Research 27, 679–684.
CW Tsao , YS Lin , CC Chen , CH Bai , SR Wu (2006). Cytokines and serotonin transporter in patients with major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 899–905.
C Tuglu , SH Kara , O Caliyurt , E Vardar , E Abay (2003). Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology 170, 429–433.
S Tyring , A Gottlieb , K Papp , K Gordon , C Leonardi , A Wang , D Lalla , M Woolley , A Jahreis , R Zitnik , D Cella , R Krishnan (2006). Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial. Lancet 367, 29–35.
NA Uranova , VM Vostrikov , DD Orlovskaya , VI Rachmanova (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophrenia Research 67, 269–275.
AM van Dam , S Poole , M Schultzberg , F Zavala , FJ Tilders (1998). Effects of peripheral administration of LPS on the expression of immunoreactive interleukin-1 alpha, beta, and receptor antagonist in rat brain. Annals of the New York Academy of Sciences 840, 128–138.
MP Vawter , L Thatcher , N Usen , TM Hyde , JE Kleinman , WJ Freed (2002). Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Molecular Psychiatry 7, 571–578.
KS Vikman , B Owe-Larsson , J Brask , KS Kristensson , RH Hill (2001). Interferon-gamma-induced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures. Brain Research 896, 18–29.
L Vitkovic J Bockaert C Jacque (2000). ‘Inflammatory’ cytokines: neuromodulators in normal brain? Journal of Neurochemistry 74, 457–471.
RM Vouimba , C Munoz , DM Diamond (2006). Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress 9, 29–40.
JL Warner-Schmidt , RS Duman (2006). Hippocampal neurogenesis: opposing effects of stress and antidepressant treatment. Hippocampus 16, 239–249.
M Wichers , M Maes (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 5, 375–388.
ME Wolf , X Sun , S Mangiavacchi , SZ Chao (2004). Psychomotor stimulants and neuronal plasticity. Neuropharmacology 47 (Suppl. 1), 61–79.
L Xu C Holscher , R Anwyl , MJ Rowan (1998). Glucocorticoid receptor and protein/RNA synthesis-dependent mechanisms underlie the control of synaptic plasticity by stress. Proceedings of the National Academy of Sciences USA 95, 3204–3208.
O Yasuhara , A Matsuo , K Terai , DG Walker , AE Berger , I Akiguchi , J Kimura , PL McGeer (1997). Expression of interleukin-1 receptor antagonist protein in post-mortem human brain tissues of Alzheimer's disease and control cases. Acta Neuropathologica 93, 414–420.
R Yirmiya (2000). Depression in medical illness: the role of the immune system. Western Journal of Medicine 173, 333–336.
R Yirmiya , Y Pollak , M Morag , A Reichenberg , O Barak , R Avitsur , Y Shavit , H Ovadia , J Weidenfeld , A Morag , ME Newman , T Pollmacher (2000). Illness, cytokines, and depression. Annals of the New York Academy of Sciences 917, 478–487.
R Yirmiya , G Winocur , I Goshen (2002). Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning. Neurobiology of Learning and Memory 78, 379–389.
CA Zarate Jr., JL Payne , J Quiroz , J Sporn , KK Denicoff , D Luckenbaugh , DS Charney , HK Manji (2004 a). An open-label trial of riluzole in patients with treatment-resistant major depression. American Journal of Psychiatry 161, 171–174.
CA Zarate Jr., JL Payne , J Singh , JA Quiroz , DA Luckenbaugh , KD Denicoff , DS Charney , HK Manji (2004 b). Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry 56, 54–60.
CA Zarate Jr., J Singh , HK Manji (2006). Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biological Psychiatry 59, 1006–1020.